PHARMACYTE BIOTECH, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $5.0M | — |
| FY2020 | — | $5.1M | $894.9K |
| FY2021 | — | $6.7M | $2.2M |
| FY2022 | — | $89.9M | $85.4M |
| FY2023 | — | $72.7M | $68.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $5.0M | — |
| FY2020 | — | $5.1M | $894.9K |
| FY2021 | — | $6.7M | $2.2M |
| FY2022 | — | $89.9M | $85.4M |
| FY2023 | — | $72.7M | $68.0M |